Myovant Stock Performance

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

The company secures a Beta (Market Risk) of -0.2991, which conveys not very significant fluctuations relative to the market. Let's try to break down what Myovant's beta means in this case. As returns on the market increase, returns on owning Myovant Sciences are expected to decrease at a much lower rate. During the bear market, Myovant Sciences is likely to outperform the market. Although it is extremely important to respect Myovant Sciences price patterns, it is better to be realistic regarding the information on equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Myovant Sciences technical indicators, you can presently evaluate if the expected return of 0.0051% will be sustainable into the future. Myovant Sciences right now secures a risk of 2.71%. Please verify Myovant Sciences standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Myovant Sciences will be following its current price movements.

Search Stock Performance 

 Myovant Performance
0 of 100
Over the last 90 days Myovant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Myovant Sciences is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more

Myovant Price Channel

Quick Ratio2.45
Fifty Two Week Low13.42
Target High Price55.00
Fifty Two Week High30.90
Target Low Price24.00

Myovant Sciences Relative Risk vs. Return Landscape

If you would invest  2,068  in Myovant Sciences on April 28, 2021 and sell it today you would lose (40.00)  from holding Myovant Sciences or give up 1.93% of portfolio value over 90 days. Myovant Sciences is currently generating 0.0051% in daily expected returns and assumes 2.7056% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Myovant, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Myovant Sciences is expected to generate 11.73 times less return on investment than the market. In addition to that, the company is 3.62 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.08 per unit of volatility.

Myovant Sciences Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Myovant Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Myovant Sciences, and traders can use it to determine the average amount a Myovant Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0019

Good Returns
Average Returns
Small Returns
Negative ReturnsMYOV
Estimated Market Risk
  actual daily
 23 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Myovant Sciences is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Myovant Sciences by adding it to a well-diversified portfolio.

About Myovant Sciences Performance

To evaluate Myovant Sciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Myovant Sciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Myovant Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Myovant Sciences stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Myovant's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Return on Average Assets(0.58) (0.63) 
Return on Average Equity 1.06  1.09 
Return on Invested Capital(1.38) (1.49) 
Return on Sales(3.71) (4.00) 
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.

Things to note about Myovant Sciences

Checking the ongoing alerts about Myovant Sciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Myovant Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Myovant Sciences Alerts

Equity Alerts and Improvement Suggestions

Myovant Sciences has a very high chance of going through financial distress in the upcoming years
Myovant Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 59.32 M. Net Loss for the year was (255.13 M) with loss before overhead, payroll, taxes, and interest of (79.36 M).
Myovant Sciences has a poor financial position based on the latest SEC disclosures
About 60.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Myovant Sciences Ltd falls 1.82 percent for July 26 -
Additionally, see Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.